An immunological concept - individually optimized for each patient
Cancer and the immune system are subject to dynamic processes that must be taken into account during treatment. IOZK immunotherapy is therefore individually tailored to each patient. Thanks to its good tolerability, it can be carried out entirely on an outpatient basis.
IOCC immunotherapy can be coordinated with other therapies such as surgery, radiotherapy or chemotherapy if required. Unlike chemotherapy or radiotherapy, which follow a fixed schedule and regimen, IOZK immunotherapy is tailored to the individual requirements of the patient. It is constantly adapted to possible changes in the tumor and the immune system.
Cancer is a chronic disease and may recur even after successful therapy. It is therefore advisable to monitor the success of the immunotherapy at certain intervals.
The exact course and duration of IOZK immunotherapy vary greatly because they depend on the type and course of the tumor disease and the patient's individual immunological response. The first step on the way to your individual immunotherapy is the initial consultation.
The initial presentation at the IOZK is used to take the patient's medical history, review all findings and discuss both conventional and possible immunological treatment options. Blood samples are then taken to examine the immune system and tumor activity, the results of which are available after around two weeks.
The team of experts meets for an internal tumor conference and discusses the results, taking into account the patient's medical history, and develops an individual therapy strategy. This combines selected modules of IOZK immunotherapy.
The recommendations of the tumor conference are then discussed with the patient. The individual therapy is planned taking the patient's wishes into account.
